Zobrazeno 1 - 10
of 10
pro vyhledávání: '"D G, Connaghan"'
Autor:
Scott R. Solomon, Asad Bashey, Karen Manion, Kathy McNatt, D G Connaghan, A M Barreras, Dawn Speckhart, Lawrence E. Morris, R H Matthews, H.K. Holland
Publikováno v:
Bone Marrow Transplantation. 45:468-475
Historically, myeloablative allogeneic hematopoietic SCT (HSCT) has required prolonged in-patient hospitalization due to the effects of mucosal toxicity and prolonged cytopenias. We explored the safety and feasibility of outpatient management of thes
Autor:
A. Farrand, Thomas D. Boyer, R. M. Strauss, A. Duncan, Michael W. Fried, George B. McDonald, J. Peter, D G Connaghan, S. Soroka
Publikováno v:
Bone Marrow Transplantation. 27:635-639
The development of hepatic veno-occlusive disease following bone marrow transplantation is associated with high-dose combination cytoreductive therapy. Experimental models have suggested that drug-induced injury to hepatic sinusoidal endothelial cell
Autor:
Steven M. Devine, Louis G. Martin, D G Connaghan, John R. Wingard, Michael W. Fried, Thomas D. Boyer, Shvetank Sharma, K Holland, Stephen L. Kaufman, A Zuckerman
Publikováno v:
Hepatology. 24:588-591
Hepatic venoocclusive disease (VOD) is a common, life-threatening complication of bone marrow transplantation (BMT). Portal hypertension is usually present and accounts for many of the clinical manifestations of this syndrome. We describe the results
Publikováno v:
Bone marrow transplantation. 39(7)
We report our experience with oral busulfan (BU) in 159 consecutive patients to evaluate the safety of home administration. Patients received a myeloablative BU-containing regimen, including oral anticonvulsant and antiemetic prophylaxis, followed by
Publikováno v:
Journal of the Medical Association of Georgia. 87(2)
Autor:
S M, Devine, R B, Geller, L B, Lin, S P, Dix, H K, Holland, D, Maurer, K, O'Toole, J, Keller, D G, Connaghan, L T, Heffner, C D, Hillyer, G E, Rodey, E F, Winton, R M, Maher, W E, Fitzsimmons, J R, Wingard
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 3(1)
Initial studies of FK506 combined with methotrexate (MTX) in patients receiving unrelated donor BMT have demonstrated a possible-decrease in the incidence of severe GVHD but high rates of severe stomatitis and nephrotoxicity. With this background, we
Publikováno v:
Blood. 65:589-597
A new method is described for identifying low concentrations of circulating derivatives of fibrinogen and fibrin, even when present in heterogeneous mixtures. This technique is applicable to plasma and serum and uses electrophoresis in 2% agarose in
Publikováno v:
American Journal of Clinical Pathology. 86:304-310
An electrophoretic method has been applied to characterize specific fibrinogen and fibrin degradation products (FDP) in 135 serum samples from 59 consecutive patients having a positive latex agglutination test for serum FDP in the evaluation of consu
Publikováno v:
Circulation. 74(5)
In a group of 39 patients who received fibrinolytic therapy for acute myocardial infarction, serum crosslinked fibrin degradation products (XLDP) were quantitated by an enzyme-linked immunosorbent assay (ELISA) using an antibody reactive with a site
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):134